Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amaryl addition to Metformin and TZD in NIDDM
NCT00044447Phase 3Completed
- Sponsor
- Sanofi
- Start
- May 2001
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of glimepiride in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started May 2001; status: completed.
02
Drugs
glimepiride
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00044447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00044447.